The efficacy of lafutidine for nab-paclitaxel-induced peripheral neuropathy
Phase 2
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000011301
- Lead Sponsor
- Yokohama City University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
1)with severe complications (such as liver failure, renal failure, heart failure) 2)with history of allergy 3)case of taking pregabalin 4)doctor's decision not to be registered to this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method